prikaz prve stranice dokumenta Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022
  Preuzmi
PDF 1.25 MB
Znanstveni rad - Pregledni rad
Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022
Bone Marrow Transplantation, 57 (2022), 8; 1217-1239. https://doi.org/10.1038/s41409-022-01691-w
(European Society for Blood and Marrow Transplantation) Snowden, John A.; Sánchez-Ortega, Isabel; Corbacioglu, Selim; Basak, Grzegorz W.; Chabannon, Christian; de la Camara, Rafael; Dolstra, Harry; Duarte, Rafael F.; Glass, Bertram; Greco, Raffaella; Lankester, Arjan C.; Mohty, Mohamad; Neven, Bénédicte; de Latour, Régis Peffault; Pedrazzoli, Paolo; Perić, Zinaida; Yakoub-Agha, Ibrahim; Sureda, Anna; Kröger, Nicolaus Više autora...

Citirajte ovaj rad

Snowden, J. A., Sánchez Ortega, I., Corbacioglu, S., Basak, G. W., Chabannon, C., de la Camara, R. ... Kröger, N. (2022). Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022. Bone Marrow Transplantation, 57. (8), 1217-1239. doi: 10.1038/s41409-022-01691-w

Snowden, John A., et al. "Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022." Bone Marrow Transplantation, vol. 57, br. 8, 2022, str. 1217-1239. https://doi.org/10.1038/s41409-022-01691-w

Snowden, John A., Isabel Sánchez Ortega, Selim Corbacioglu, Grzegorz W. Basak, Christian Chabannon, Rafael de la Camara, Harry Dolstra, et al. "Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022." Bone Marrow Transplantation 57, br. 8 (2022): 1217-1239. https://doi.org/10.1038/s41409-022-01691-w

Snowden, J. A., et al. (2022) 'Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022', Bone Marrow Transplantation, 57(8), str. 1217-1239. doi: 10.1038/s41409-022-01691-w

Snowden JA, Sánchez Ortega I, Corbacioglu S, Basak GW, Chabannon C, de la Camara R, i sur.. Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022. Bone Marrow Transplantation [Internet]. 19.05.2022. [pristupljeno 18.05.2024.];57(8):1217-1239. doi: 10.1038/s41409-022-01691-w

J. A. Snowden, et al., "Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022", Bone Marrow Transplantation, vol. 57, br. 8, str. 1217-1239, Svibanj 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:756558. [Citirano: 18.05.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:756558
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022
AutorJohn A. Snowden
AutorIsabel Sánchez-Ortega
AutorSelim Corbacioglu
AutorGrzegorz W. Basak
AutorChristian Chabannon
AutorRafael de la Camara
AutorHarry Dolstra
AutorRafael F. Duarte
AutorBertram Glass
AutorRaffaella Greco
AutorArjan C. Lankester
AutorMohamad Mohty
AutorBénédicte Neven
AutorRégis Peffault de Latour
AutorPaolo Pedrazzoli
AutorZinaida Perić
AutorIbrahim Yakoub-Agha
AutorAnna Sureda
AutorNicolaus Kröger
KolaboracijaEuropean Society for Blood and Marrow Transplantation
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA INTERNU MEDICINU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
For over two decades, the EBMT has updated recommendations on indications for haematopoietic cell transplantation (HCT) practice based on clinical and scientific developments in the field. This is the eighth special EBMT report on the indications for HCT for haematological diseases, solid tumours and immune disorders. Our aim is to provide general guidance on HCT indications according to prevailing clinical practice in EBMT countries and centres. In order to inform patient decisions, these recommendations must be considered in conjunction with the risk of the disease, risk of HCT procedure and non-transplant strategies, including evolving cellular therapies. HCT techniques are constantly evolving and we make no specific recommendations, but encourage harmonisation of practice, where possible, to ensure experience across indications can be meaningfully aggregated via registry outputs. We also recommend working according to JACIE accreditation standards to maintain quality in clinical and laboratory components of practice, including benchmarking of survival outcomes. Since the last edition, the COVID-19 pandemic has affected clinical decision making and activity across indications. Although the full impact of the pandemic is yet to be determined, we recommend that decision making across indications is delivered with ongoing reference to EBMT and national COVID-19 guidance, in accordance with current local conditions.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Pregledni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaBone Marrow Transplantation
Brojčani podacivol. 57, br. 8, str. 1217-1239
p-ISSN0268-3369
e-ISSN1476-5365
DOIhttps://doi.org/10.1038/s41409-022-01691-w
URN:NBNurn:nbn:hr:105:756558
Datum objave publikacije2022-05-19
URL dokumentahttps://www.nature.com/articles/s41409-022-01691-w
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje 4.0 međunarodna (CC BY 4.0)
Datum i vrijeme pohrane2022-12-15 08:34:00